Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
My69z's Profile
Displaying 501-550 of 1158 result(s).
CYDY CytoDyn Inc
10/28/2024 1:05:11 AM
*2015, ViiV Healthcare partnered wi (1)
CYDY CytoDyn Inc
10/27/2024 10:28:29 AM
Max/GSK/FDA/Fostemsavir: Meeting Ca (18)
CYDY CytoDyn Inc
10/26/2024 11:20:15 PM
He's been involved with around 5-6 (4)
CYDY CytoDyn Inc
10/26/2024 10:31:14 AM
Great bio on Max: https://ctcase.or (5)
CYDY CytoDyn Inc
10/25/2024 11:45:42 PM
Typically, at GSK, we design: * To (6)
CYDY CytoDyn Inc
10/24/2024 11:14:19 PM
GSK owns 27% Samsung Bio. https://w (13)
CYDY CytoDyn Inc
10/24/2024 10:19:08 AM
Through Quest. Another collab conne (2)
CYDY CytoDyn Inc
10/24/2024 9:36:37 AM
GSK4532990 Fibrosis/Inflammation: h (1)
CYDY CytoDyn Inc
10/23/2024 9:36:45 PM
GSK's CCR5 --- '06. * Dr. J 2006 pu (2)
CYDY CytoDyn Inc
10/23/2024 9:24:51 PM
Ken, this is very good. Ckean-cut f (3)
CYDY CytoDyn Inc
10/22/2024 7:13:52 PM
Kat, you said: " But ViiV Got its h (4)
CYDY CytoDyn Inc
10/22/2024 9:22:59 AM
Thx Kat -- outstanding reply. " The (6)
CYDY CytoDyn Inc
10/22/2024 1:22:47 AM
GSK R&D sites: https://www.gsk.com/ (2)
CYDY CytoDyn Inc
10/22/2024 1:03:35 AM
Dr Max Lataillade Bristol-Myers Squ (12)
CYDY CytoDyn Inc
10/21/2024 8:36:20 PM
GSK/Pfizer Maraviroc goal: "Pfizerâ (3)
CYDY CytoDyn Inc
10/21/2024 7:57:38 PM
Absolutey. Pointed that out couple (1)
CYDY CytoDyn Inc
10/21/2024 7:53:16 PM
Oh, see why I most likely confused (2)
CYDY CytoDyn Inc
10/21/2024 7:45:07 PM
Actually June 2025 --- glad you ask (4)
CYDY CytoDyn Inc
10/21/2024 7:19:52 PM
06/21: back dating to ViiV advisor. (1)
CYDY CytoDyn Inc
10/21/2024 6:03:16 PM
Lishomwa C. Ndhlovu is supported an (1)
CYDY CytoDyn Inc
10/20/2024 6:21:36 AM
You've never used 2 strong positive (1)
CYDY CytoDyn Inc
10/20/2024 1:37:31 AM
Wouldn't cognitive get cross-linked
CYDY CytoDyn Inc
10/20/2024 1:29:53 AM
Your comment -- sad how true. You c
CYDY CytoDyn Inc
10/20/2024 12:13:13 AM
Gaudinski / GSK / VRC07-523LS: 2019 (6)
CYDY CytoDyn Inc
10/18/2024 10:26:33 PM
SAE -- Leronlimab (0/28). Placebo ( (2)
CYDY CytoDyn Inc
10/18/2024 9:20:20 PM
Long Covid results -- 4/2024. Submi (7)
CYDY CytoDyn Inc
10/18/2024 8:40:06 AM
Consider this: Dr. Lataillade hirin (10)
CYDY CytoDyn Inc
10/17/2024 6:34:41 PM
Dr. Lataillade ViiV date: VH3810109 (6)
CYDY CytoDyn Inc
10/17/2024 8:22:14 AM
Lalezari/Deeks/Martin: The SCOPE c (3)
CYDY CytoDyn Inc
10/16/2024 9:38:16 PM
It's autocorrect!!...hahaaa Yea...b (2)
CYDY CytoDyn Inc
10/16/2024 9:15:22 PM
Our problem is awareness --- not 50 (3)
CYDY CytoDyn Inc
10/16/2024 8:56:07 PM
" But I highly doubt that she will (3)
CYDY CytoDyn Inc
10/16/2024 10:54:38 AM
Yes. All non-votes default to compa (1)
CYDY CytoDyn Inc
10/16/2024 2:23:45 AM
This is our hint to a deal. Just re (5)
CYDY CytoDyn Inc
10/16/2024 2:04:07 AM
With $24m @ 8/31/2024: Below has oc (18)
CYDY CytoDyn Inc
10/15/2024 6:42:05 PM
Tears of joy. Ha. : )
CYDY CytoDyn Inc
10/15/2024 6:28:08 PM
.02 cents = longs in tears..LOL! ht (2)
CYDY CytoDyn Inc
10/15/2024 6:18:17 PM
10K is out.
CYDY CytoDyn Inc
10/15/2024 6:10:49 PM
" We believe the Company has suffic (4)
CYDY CytoDyn Inc
10/15/2024 6:01:24 PM
Kat, combo trial VRC07-523LS & PGT1 (1)
CYDY CytoDyn Inc
10/15/2024 5:49:37 PM
Thx 2 u guys chazzle --- & I was sl (1)
CYDY CytoDyn Inc
10/15/2024 5:44:28 PM
Oh hell no. Not subverting them @ a (4)
CYDY CytoDyn Inc
10/15/2024 5:27:24 PM
Testing PGT121 combo scenario, woul
CYDY CytoDyn Inc
10/15/2024 10:15:48 AM
Nt2, add this & also along the line
CYDY CytoDyn Inc
10/15/2024 4:24:24 AM
Does this help too: Antiviral activ
CYDY CytoDyn Inc
10/15/2024 4:10:50 AM
30 yrs. Wow. I agree on his hiring. (6)
CYDY CytoDyn Inc
10/15/2024 3:24:26 AM
This is great info & outstanding to (1)
CYDY CytoDyn Inc
10/15/2024 3:22:24 AM
& Kat..the thing about Leronlimab w
CYDY CytoDyn Inc
10/15/2024 3:14:57 AM
Apologies -- I was focusing on the (1)
CYDY CytoDyn Inc
10/15/2024 2:59:38 AM
You'll like this correction!!!... " (4)
Go to page:
  • << First
  • < Previous
  • 10
  • 11
  • Next >

Recent Articles

  • Explore RICH Miner's New App for Seamless Crypto Earning
  • Exploring the Future of Maritime Innovation with Energy Observer
  • Neo Pepe Coin Revolutionizes the Meme Coin Market with Growth
  • Consolidated Lithium Mines New Discoveries and Successful Funding
  • Comprehensive Overview of Treasury Bonds Auction Results
  • Exciting Developments in Lithium Exploration and Financing
  • Petro-Victory Energy Partners with ATE for Strategic Growth
  • Forte and Sequence Collaborate to Enhance Web3 Payment Solutions
  • Identifying Cloud Spending Excess: Insights from Cherry Servers
  • Future Growth of Cryptocurrency Mining Hardware Analyzed
  • Toobit's Innovative Growth and Achievements in 2025 So Far
  • Little Pepe Sets New Standards as Ethereum's Leading Meme Token
  • Understanding Counterparty Risk Management for Today’s Markets
  • Significant Milestones for Lightchain AI: Final Round Launch
  • Navigating the New Supervisory Board Selection at Ignitis Group
  • Lottery.com and Sports.com Drivers Gear Up for Exciting Race Weekend
  • NorthWest Copper Secures Funding to Accelerate Exploration Efforts
  • Transforming Real Estate: The Future is Tokenization
  • Exciting Racing Action: Lottery.com and Sports.com Drivers Gearing Up
  • NorthWest Copper Secures Funding to Enhance Kwanika Project Value
  • Public Disclosure of Position by Danske Bank in Alpha Group
  • Insightful Update on Alpha Group International PLC's Positions
  • Carbon Fiber & CFRP Market Anticipated Growth Towards $35.55 Billion
  • Innovative Care Management Solutions for Enhanced Healthcare Delivery
  • Coinbase's Growth Driven by Regulatory Shifts and Innovation
  • Revamping Real Estate Investment: Blockchain and Ownership
  • Autozi Internet Technology Receives Compliance Notice from Nasdaq
  • HitGen Takes Bold Steps with Sustainability Report Release
  • Understanding the Transformative Power of ESG in Investments
  • Shaping the Future of ESG: Global Regulatory Trends Influence
  • Significant Unit Split Announced by Partners Value Investments
  • Surge in Hong Kong IPOs Signals Shift for Chinese Companies
  • Big Savings with NAIPO and MaxKare During Walmart Deals!
  • Insights into H&T Group's Public Dealing Disclosure Practices
  • Home Hydroponics Market Set to Reach $3.77 Billion by 2030
  • Immuthera's Advisory Board: Pioneering New Frontiers in Diabetes Care
  • Immuthera's Expert Team Paving the Way for Diabetes And Immunotherapy
  • Yingfa Ruineng's Commitment to Sustainable Photovoltaics
  • Virbac Announces Total Number of Shares and Voting Rights
  • Empower Your Retirement: Unlock Wealth with New Tool
  • AB Ignitis Group Launches Search for New Supervisory Board
  • Insight into Danish Ship Finance A/S and Their Base Prospectus
  • Aalborg Municipality Enhances Governance with cBrain’s F2 Platform
  • Tarkett: Overview of Voting Rights and Share Capital Today
  • Tarkett Updates on Share Capital and Voting Rights Details
  • Exciting Housing Initiative to be Announced by Federal Officials
  • Yingfa Ruineng's Commitment to Sustainability and Innovation
  • Exciting Dividend Growth Opportunities to Watch This Quarter
  • Insight into Dimensional Fund Advisors Ltd.'s Recent Activities
  • Dimensional Fund Advisors Discloses Position in Mitie Group PLC
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site